FDA 483 - Mylan Laboratories Limited - May 17, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Mylan Laboratories Limited, a sterile drug manufacturer in Hosur, India, was inspected and cited for significant deficiencies in aseptic processing, cleaning validation, and quality control. Observations included inadequate cleaning and disinfection systems, insufficient aseptic process validation, failure to investigate recurring microbial contamination, and non-compliance with Field Alert Report requirements. These issues indicate a high risk to the sterility and quality of drug products.
ID · d4e40876-3354-4df3-ba51-e04ce26608b8